Literature DB >> 26673968

Screening of Peroxisome Proliferator-Activated Receptors (PPARs) α, γ and α Gene Polymorphisms for Obesity and Metabolic Syndrome Association in the Multi-Ethnic Malaysian Population.

Phee-Phee Chia1, Sook-Ha Fan2, Yee-How Say2.   

Abstract

OBJECTIVE: This study aimed to investigate the association of peroxisome proliferator-activated receptor (PPAR) genes PPARα L162V, PPARγ2 C161T and PPARδ T294C single nucleotide polymorphisms (SNPs) with obesity and metabolic syndrome (Met-S) in a multi-ethnic population in Kampar, Malaysia.
METHODS: Socio-demographic data, anthropometric and biochemical measurements (plasma lipid profile, adiponectin and interleukin-6 [IL-6] levels) were taken from 307 participants (124 males; 180 obese; 249 Met-S; 97 Malays, 85 ethnic Chinese, 55 ethnic Indians).
RESULTS: The overall minor allele frequencies were .08, .22 and .30 for PPAR α L162V, γ C161T, δ T294C, respectively. All SNPs were not associated with obesity, Met-S and obesity with/without Met-S by χ(2) analysis, ethnicity-stratified and logistic regression analyses. Nevertheless, participants with V162 allele of PPARα had significantly higher IL-6, while those with T161 allele of PPARγ2 had significantly lower HOMA-IR.
CONCLUSIONS: All PPAR SNPs were not associated with obesity and Met-S in the suburban population of Kampar, Malaysia, where only PPARα V162 and PPARγ2 T161 alleles were associated with plasma IL-6 and HOMA-IR, respectively.

Entities:  

Keywords:  Malaysia; Metabolic Syndrome; Obesity; Peroxisome Proliferator-Activated Receptors; Single Nucleotide Polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26673968      PMCID: PMC4671443          DOI: 10.18865/ed.25.4.383

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  49 in total

1.  Peroxisome proliferator-activated receptor-delta polymorphisms are associated with physical performance and plasma lipids: the HERITAGE Family Study.

Authors:  Arto J Hautala; Arthur S Leon; James S Skinner; D C Rao; Claude Bouchard; Tuomo Rankinen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-01-26       Impact factor: 4.733

2.  A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans.

Authors:  A Meirhaeghe; L Fajas; N Helbecque; D Cottel; P Lebel; J Dallongeville; S Deeb; J Auwerx; P Amouyel
Journal:  Hum Mol Genet       Date:  1998-03       Impact factor: 6.150

3.  The dependence of serum interleukin-6 level on PPAR-alpha polymorphism in men with coronary atherosclerosis.

Authors:  Anna Skoczynska; Tadeusz Dobosz; Rafal Poreba; Barbara Turczyn; Arkadiusz Derkacz; Magdalena Zoledziewska; Anna Jonkisz; Arleta Lebioda
Journal:  Eur J Intern Med       Date:  2005-11       Impact factor: 4.487

4.  Association of PPAR-γ gene polymorphisms with obesity and obesity-associated phenotypes in North Indian population.

Authors:  Jai Prakash; Neena Srivastava; Shally Awasthi; C Agarwal; S Natu; Naresh Rajpal; Balraj Mittal
Journal:  Am J Hum Biol       Date:  2012-03-12       Impact factor: 1.937

5.  Peroxisome proliferator-activated receptor gamma C161-->T polymorphism and coronary artery disease.

Authors:  X L Wang; J Oosterhof; N Duarte
Journal:  Cardiovasc Res       Date:  1999-12       Impact factor: 10.787

6.  Peroxisome proliferator-activated receptor [alpha] genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study.

Authors:  Kelly A Volcik; Jennifer A Nettleton; Christie M Ballantyne; Eric Boerwinkle
Journal:  Am J Clin Nutr       Date:  2008-06       Impact factor: 7.045

7.  No association between peroxisome proliferator-activated receptor and uncoupling protein gene polymorphisms and obesity in Malaysian university students.

Authors:  Sin-Keat Yiew; Li-Yin Khor; Mee-Lay Tan; Chia-Li Pang; Voon-Yun Chai; Sathia S Kanachamy; Yee-How Say
Journal:  Obes Res Clin Pract       Date:  2010 Oct-Dec       Impact factor: 2.288

8.  Impact of peroxisome proliferator-activated receptors gamma and delta on adiposity in toddlers and preschoolers in the GENESIS Study.

Authors:  Vasiliki Lagou; Robert A Scott; Yannis Manios; Tun-Li Joshua Chen; Guan Wang; Evangelia Grammatikaki; Christine Kortsalioudaki; Thodoris Liarigkovinos; George Moschonis; Eleftheria Roma-Giannikou; Yannis P Pitsiladis
Journal:  Obesity (Silver Spring)       Date:  2008-01-31       Impact factor: 5.002

9.  Single-nucleotide polymorphisms in peroxisome proliferator-activated receptor gamma and their association with plasma levels of resistin and the metabolic syndrome in a South Indian population.

Authors:  Abdul Haseeb; Mohammad Iliyas; Subhabrata Chakrabarti; Arif A Farooqui; Sudhir R Naik; Sudip Ghosh; Madhuri Suragani; Nasreen Z Ehtesham
Journal:  J Biosci       Date:  2009-09       Impact factor: 1.826

10.  PPARalpha L162V underlies variation in serum triglycerides and subcutaneous fat volume in young males.

Authors:  Julieta Uthurralt; Heather Gordish-Dressman; Meg Bradbury; Carolina Tesi-Rocha; Joseph Devaney; Brennan Harmon; Erica K Reeves; Cinzia Brandoli; Barbara C Hansen; Richard L Seip; Paul D Thompson; Thomas B Price; Theodore J Angelopoulos; Priscilla M Clarkson; Niall M Moyna; Linda S Pescatello; Paul S Visich; Robert F Zoeller; Paul M Gordon; Eric P Hoffman
Journal:  BMC Med Genet       Date:  2007-08-16       Impact factor: 2.103

View more
  4 in total

1.  G Allele of the rs1801282 Polymorphism in PPARγ Gene Confers an Increased Risk of Obesity and Hypercholesterolemia, While T Allele of the rs3856806 Polymorphism Displays a Protective Role Against Dyslipidemia: A Systematic Review and Meta-Analysis.

Authors:  Shujin Li; Chuan He; Haiyan Nie; Qianyin Pang; Ruixia Wang; Zhifu Zeng; Yongyan Song
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

Review 2.  An update on obesity research pattern among adults in Malaysia: a scoping review.

Authors:  Noor Safiza Mohamad Nor; Rashidah Ambak; Norazian Mohd Zaki; Nur Shahida Abdul Aziz; Siew Man Cheong; Mohamad Aznuddin Abd Razak; Muslimah Yusof; Mohamad Hasnan Ahmad; Azli Baharuddin; Megat Rusydi Megat Radzi; Wan Nur Khairunnisa Wan Kozil; Intan Hafizah Ishak; Tahir Aris
Journal:  BMC Womens Health       Date:  2018-07-19       Impact factor: 2.809

3.  Metabolic Syndrome and Incidence of Laryngeal Cancer: A Nationwide Cohort Study.

Authors:  Sang-Yeon Kim; Kyung-do Han; Young-Hoon Joo
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

4.  The effect of metabolic syndrome on head and neck cancer incidence risk: a population-based prospective cohort study.

Authors:  Huaili Jiang; Lei Zhou; Qiangsheng He; Kanglun Jiang; Jinqiu Yuan; Xinsheng Huang
Journal:  Cancer Metab       Date:  2021-06-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.